ECO Animal Health Group (EAH)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

131.29p
   
  • Change Today:
    -0.21p
  • 52 Week High: 132.49
  • 52 Week Low: 84.00
  • Currency: UK Pounds
  • Shares Issued: 67.74m
  • Volume: 63,964
  • Market Cap: £88.95m

Revenue falls slightly at ECO Animal Health Group

Date: Wednesday 12 Dec 2012

LONDON (ShareCast) - AIM-listed ECO Animal Health Group reported a slight reduction in its revenue for the six month period ending September 30th, according to the group’s half yearly report.

The company, which develops pharmaceutical products for the global animal health markets, stated that its revenue was £11.46m compared to £11.88m for the corresponding period last year.

Gross profit rose 14.7% to £5.1m and earnings before interest, tax, depreciation, amortisation, share based payments and foreign exchange movements, amounted to £2.0m. This was less than the £2.3m generated in the same period in 2011, but reflected product launch costs of £0.3m in the US and Canada.

Peter Lawrence, Executive Chairman of the group, said: “In the light of the many new opportunities opening up to the group, we are concentrating our management and financial resources on those products and markets with the greatest potential for profitable growth and reducing exposure to those with limited margins and restricted growth potential.

Unpredictable timing of orders in Latin America affects sales

“The success of this strategy is reflected in overall sales in the period of £11.45m (2011: £11.88m) which were a little lower than last year’s level, mainly due to Latin America where the timing of orders, coupled with the availability of foreign currency can be unpredictable but, in the medium term these issues have tended to unwind. Nevertheless, these factors were more than outweighed by the significant improvement in margin and gross profit.”

He added: “The second half of the year is traditionally a stronger trading period as the incidence of respiratory disease increases and parasite numbers rise during the southern hemisphere spring and it is pleasing to note that our performance in the first two months of the second half has been strong. These traditional factors, coupled with the exciting sales opportunities offered by our entry into new markets for Aivlosin in Canada, the USA and Russia, enable us to look forward with confidence and we expect to deliver another sound full year result for our shareholders.”

ECO animal Health Group’s share price was up 0.20% to 252.50p at 11:54 on Wednesday.

MF

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

EAH Market Data

Currency UK Pounds
Share Price 131.29p
Change Today -0.21p
% Change -0.16 %
52 Week High 132.49
52 Week Low 84.00
Volume 63,964
Shares Issued 67.74m
Market Cap £88.95m

EAH Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.27% below the market average35.27% below the market average35.27% below the market average35.27% below the market average35.27% below the market average
49.02% above the sector average49.02% above the sector average49.02% above the sector average49.02% above the sector average49.02% above the sector average
Price Trend
75.03% above the market average75.03% above the market average75.03% above the market average75.03% above the market average75.03% above the market average
88.68% above the sector average88.68% above the sector average88.68% above the sector average88.68% above the sector average88.68% above the sector average
Income Not Available
Growth
23.57% above the market average23.57% above the market average23.57% above the market average23.57% above the market average23.57% above the market average
54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average

What The Brokers Say

Strong Buy 1
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 3
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

EAH Dividends

  Latest Previous
  Final Final
Ex-Div 23-Sep-21 26-Sep-19
Paid 22-Oct-21 16-Oct-19
Amount 1.00p 7.04p

Trades for 10-Jun-2024

Time Volume / Share Price
15:29 1,000 @ 128.56p
15:10 139 @ 132.00p
14:06 20,000 @ 128.50p
14:12 26 @ 128.56p
14:10 18 @ 129.10p

EAH Key Personnel

CFO Christopher Wilks
CEO David Hallas

Top of Page